Clinical Trials Browser

Phase 2 × Unknown × Drug Evaluation × Clear all

NCT04121039 2019-10-09

Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Gastric Adenocarcinoma

NCT04088110 2019-09-12

Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Phase 2 Unknown

Breast Diseases, Breast Neoplasms

NCT03910712 2019-04-10

Pyrotinib

Phase 2 Unknown

Breast Diseases, Breast Neoplasms